NOTE 4 - CAPITAL STOCK | Capitalization The authorized capital of the Company is 500,000,000 shares of capital stock, divided into 480,000,000 shares of common stock with a par value of $0.001 per share, and 20,000,000 shares of preferred stock with a par value of $0.001 per share. The Company reserved 10,000,000 shares of common stock for issuance under its 2016 Omnibus Equity Incentive Plan. The Company has issued 50,605,965 common shares and no preferred shares. No shares were issued during the years ended December 31, 2020 and 2019. Options A total of 10,000,000 options are issued and outstanding, all of which were vested by December 31, 2020. On November 20, 2018, the Company granted 500,000 non-qualified stock options pursuant to the Equity Incentive Plan, to key outside consultants, with 50% vesting after one year and 50% vesting after two years. Each option is exercisable into one share of the Company’s common stock at a price of $0.06 per share, for a term of five years. For the year ended December 31, 2020, $3,535 (2019 - $10,562) was included in consulting services expense, based on fair value estimates determined using the Black-Scholes option pricing model with an average risk-free rate of 2.88%, a weighted average life of 5 years, volatility of 195.37%, and dividend yield of 0%. At December 31, 2020, the options had an intrinsic value of $40,000 ($2019 - $7,000) based on the exercise price of $0.06 per option and a market price of $0.14 per share. On February 14, 2017, the Company granted 9,500,000 non-qualified stock options pursuant to the Equity Incentive Plan, to key corporate officers and outside consultants, with 25% vesting immediately and a further 25% vesting every six months thereafter for eighteen months. Each option is exercisable into one share of the Company’s common stock at a price of $0.06 per share, equal to the closing price of the common stock on the grant date, for a term of five years. The options were fully amortized by the end of 2018, so for the years ended December 31, 2020 and 2019, no related amounts were included in consulting services expense. At December 31, 2020, the options had an intrinsic value of $760,000 (2019 - $133,000) based on the exercise price of $0.06 per option and a market price of $0.14 per share. Summary of option activity in the current year and options outstanding at December 31, 2020: Options Years Issued Vested Weighted Average Expiry Date December 31, 2020 Issued February 14, 2017 9,500,000 9,500,000 February 14, 2022 $760,000 Exercise Price: $0.06 Issued November 20, 2018 500,000 250,000 November 20, 2023 $40,000 Exercise Price: $0.06 Balance December 31, 2019 10,000,000 9,750,000 2.21 Issued / Expired / Exercised - - Vested - 250,000 Balance December 31, 2020 10,000,000 10,000,000 1.21 $800,000 50,000 of the options issued on November 20, 2018 were exercised subsequent to year end, on March 4, 2021 on a cashless basis, resulting in the issuance of 28,571 common shares. Warrants During the years ended December 31, 2020 and 2019, no warrants to purchase shares of common stock were issued and no warrants were exercised. On November 19, 2020, 3,336,060 warrants issued in 2015 expired without being exercised, leaving no intrinsic value at December 31, 2020. At December 31, 2019 they had an intrinsic value of $180,147, based on the exercise price of $0.02 per warrant and a market price of $0.074 per share. Summary of warrant activity in the current year and warrants outstanding at December 31, 2020: Number of Exercise Weighted Weighted Expiry Date Intrinsic Value Balance December 31, 2019 and 2018 3,336,060 $ 0.02 $ 0.02 0.89 November 19, 2020 Issued - - - - - - Expired (3,336,060 ) - - - - - Exercised - - - - - - Balance outstanding and exercisable December 31, 2020 - - - - - - |